InsidersTradesSigma
Follow the 4DX stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares trade on the AU market, under the supervision of ASX. Market capitalisation: €2.4bn. The latest transaction was disclosed on 10 July 2026 (Initial Substantial Holding). Among the most active insiders: 2. Details of voting power. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 4DX Hold (neutral), based on 3 analysts. Average price target: A$4.97.
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,145 of 29,063 companies
38.9
score / 100
Value30
Quality48
FCF yld-1.7%
Earn yld-1.5%
EV/EBITDA·
ROE-174%
Gross mgn92%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 July 2026
Declarations5 total
ShareASXASX:2924-03110043-3A697003
0ShareASXASX:2924-03104476-3A696076
ShareASXASX:2924-03104103-3A696004
ShareASXASX:2924-03086279-3A692625
ShareASXASX:2924-03083235-3A692104
5 of 5 declarations
关于 4DX
4DX是一家在XASX上市的公司，专注于医疗保健领域创新技术的开发。它致力于通过数据驱动的解决方案来增强医疗治疗。